Caracemide

Research use only, not for human use.

Caracemide inhibits the enzyme ribonucleotide reductase of Escherichia coli. Caracemide can be used in anticancer studies.

Caracemide inhibits the enzyme ribonucleotide reductase of Escherichia coli. Caracemide can be used in anticancer studies.(In Vitro):Caracemide produces severe central nervous system (CNS) toxicity because of the toxic metabolite, methylisocyanate (MIC). Caracemide inactivates R1 by covalent modification at the substrate-binding site.(In Vivo):After administration of Caracemide (6.6 mg/kg;i.p.), the mercapturic acid derivative AMCC was identified in rats urine.

NSC-253272

Others

Other Targets

Anti-infection; Bacterial

——

——

81424-67-1

189.2

C6H11N3O4

>98% (HPLC)

——

CNC(=O)ON(C(C)=O)C(=O)NC

——

(-20℃)

With Ice Pack

≥ 2 years